Enhancing neural stem cell response to SDF-1α gradients through hyaluronic acid-laminin hydrogels

Biomaterials

Volumn 72, Issue , 2015, Pages 11-19

  Addington, C P ^a   Heffernan, J M ^a,b   Millar Haskell, C S ^a   Tucker, E W ^a   Sirianni, R W ^a,b   Stabenfeldt, S E ^a  

^a Arizona State University   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Brain injury; Chemotaxis; Regenerative medicine; SDF 1 CXCR4 axis; Tissue engineering

Indexed keywords

BIOCHEMISTRY; BRAIN; CELLS; CYTOLOGY; HYDROGELS; ORGANIC ACIDS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

BRAIN INJURY; CHEMOTAXIS; CLINICAL TREATMENTS; REGENERATIVE MEDICINE; STANDARD PROTEINS; STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURIES; UPREGULATED EXPRESSION;

HYALURONIC ACID;

CHEMOKINE RECEPTOR CXCR4; HYALURONIC ACID; LAMININ; STROMAL CELL DERIVED FACTOR 1ALPHA; HYDROGEL; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; HYDROGEL; MOUSE; NERVOUS SYSTEM INJURY; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL COUNT; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHARMACOLOGY;

ANIMALS; CELL COUNT; CELL SURVIVAL; CHEMOKINE CXCL12; CHEMOTAXIS; HYALURONIC ACID; HYDROGELS; LAMININ; MICE, INBRED C57BL; NEURAL STEM CELLS; RECEPTORS, CXCR4; UP-REGULATION;

EID: 84943267338     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.08.041     Document Type: Article

References (67)

1. Thurman D., Guerrero J. Trends in hospitalization associated with traumatic brain injury. J. Am. Med. Assoc. 1999, 282:954-957.
2. Coronado V.G., McGuire L.C., Sarmiento K., Bell J., Lionbarger M.R., Jones C.D., et al. Trends in traumatic brain injury in the U.S. and the public health response: 1995-2009. J. Saf. Res. 2012, 43:299-307.
3. Arbour R.B. Traumatic brain injury pathophysiology, monitoring, and mechanism-based care. Crit. Care Nurs. Clin. N. Am. 2013, 25:297-319.
4. Nolan S. Traumatic brain injury: a review. Crit. Care Nurs. Q. 2005, 28:188-194.
5. McAllister T.W. Neurobiological consequences of traumatic brain injury. Dialogues Clin. Neurosci. 2011, 13:287.
6. McKee A.C., Cantu R.C., Nowinski C.J., Hedley-Whyte E.T., Gavett B.E., Budson A.E., et al. Chronic traumatic encephalopathy in athletes. J. Neuropathol. Exp. Neurol. 2009, 68:709-735.
7. Wennersten A., Meijer X., Holmin S., Wahlberg L., Mathiesen T. Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury. J. Neurosurg. 2004, 100:88-96.
8. Harting M.T., Sloan L.A.E., Jimenez F., Baumgartner J., Cox C.S. Subacute neural stem cell therapy for traumatic brain injury. J. Surg. Res. 2009, 153:188-194.
9. Harting M.T., Baumgartner J.E., Worth L.L., Ewing-Cobbs L., Gee A.P., Day M.-C., et al. Cell therapies for traumatic brain injury. Neurosurg. Focus 2008, 24:E18.
10. Riess P., Zhang C., Saatman K.E., Laurer H.L., Longhi L.G., Raghupathi R., et al. Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 2002, 51:1043-1054.
11. Morganti-Kossmann M.C., Rancan M., Otto V.I., Stahel P.F., Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001, 16:165-177.
12. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.
13. Hicks R.R., Martin V.B., Zhang L., Seroogy K.B. Mild experimental brain injury differentially alters the expression of neurotrophin and neurotrophin receptor mRNAs in the hippocampus. Exp. Neurol. 1999, 160:469-478.
14. Imitola J., Raddassi K., Park K.I., Mueller F.-J., Nieto M., Teng Y.D., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. 2004, 101:18117-18122.
15. Itoh T., Satou T., Ishida H., Nishida S., Tsubaki M., Hashimoto S., et al. The relationship between SDF-1 α/CXCR4 and neural stem cells appearing in damaged area after traumatic brain injury in rats. Neurol. Res. 2009, 31:90-102.
16. Bignami A., Hosley M., Dahl D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat. Embryol. (Berl) 1993, 188:419-433.
17. Bonneh-Barkay D., Wiley C.A. Brain extracellular matrix in neurodegeneration. Brain Pathol. 2009, 19:573-585.
18. Lindwall C., Olsson M., Osman A.M., Kuhn H.G., Curtis M.A. Selective expression of hyaluronan and receptor for hyaluronan mediated motility (Rhamm) in the adult mouse subventricular zone and rostral migratory stream and in ischemic cortex. Brain Res. 2013, 1503:62-77.
19. Brännvall K., Bergman K., Wallenquist U., Svahn S., Bowden T., Hilborn J., et al. Enhanced neuronal differentiation in a three-dimensional collagen-hyaluronan matrix. J. Neurosci. Res. 2007, 85:2138-2146.
20. Tian W.M., Hou S.P., Ma J., Zhang C.L., Xu Q.Y., Lee I.S., et al. Hyaluronic acid-poly-D-lysine-based three-dimensional hydrogel for traumatic brain injury. Tissue Eng. 2005, 11:513-525.
21. Wei Y.T., Tian W.M., Yu X., Cui F.Z., Hou S.P., Xu Q.Y., et al. Hyaluronic acid hydrogels with IKVAV peptides for tissue repair and axonal regeneration in an injured rat brain. Biomed. Mater. 2007, 2:S142-S146.
22. Wang Y., Wei Y.T., Zu Z.H., Ju R.K., Guo M.Y., Wang X.M., et al. Combination of hyaluronic acid hydrogel scaffold and PLGA microspheres for supporting survival of neural stem cells. Pharm. Res. 2011, 28:1406-1414.
23. Lisignoli G., Cristino S., Piacentini A., Cavallo C., Caplan A.I., Facchini A. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: involvement of Cd44 and Cd54. J. Cell. Physiol. 2006, 207:364-373.
24. Purcell B.P., Elser J.A., Mu A., Margulies K.B., Burdick J.A. Synergistic effects of SDF-1a chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials 2012, 33:7849-7857.
25. Avigdor A. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004, 103:2981-2989.
26. Naruse M., Shibasaki K., Yokoyama S., Kurachi M., Ishizaki Y. Dynamic Changes of CD44 expression from progenitors to subpopulations of astrocytes and neurons in developing cerebellum. PLoS One 2013, 8:e53109.
27. Liu Y., Han S.S.W., Wu Y., Tuohy T.M.F., Xue H., Cai J., et al. CD44 expression identifies astrocyte-restricted precursor cells. Dev. Biol. 2004, 276:31-46.
28. Shu X.Z., Ghosh K., Liu Y., Palumbo F.S., Luo Y., Clark R.A., et al. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J. Biomed. Mater. Res. 2003, 68A:365-375.
29. Addington C.P., Pauken C.M., Caplan M.R., Stabenfeldt S.E. The role of SDF-1α-ECM crosstalk in determining neural stem cell fate. Biomaterials 2014, 35:3263-3272.
30. Vercruysse K.P., Marecak D.M., Marecek J.F., Prestwich G.D. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjugate Chem. 1997, 8:686-694.
31. Shu X.Z., Liu Y., Palumbo F., Prestwich G.D. Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 2003, 24:3825-3834.
32. ELLMAN G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
33. Heffernan J.M., Overstreet D.J., Le L.D., Vernon B.L., Sirianni R.W. Bioengineered scaffolds for 3D analysis of glioblastoma proliferation and invasion. Ann. Biomed. Eng. 2014, 43:1965-1977.
34. Azari H., Sharififar S., Rahman M., Ansari S., Reynolds B.A. Establishing Embryonic Mouse Neural Stem Cell Culture Using the Neurosphere Assay. J. Vis. Exp. 2011, e2457.
35. Lu Y.-B., Franze K., Seifert G., Steinhäuser C., Kirchhoff F., Wolburg H., et al. Viscoelastic properties of individual glial cells and neurons in the CNS. Proc. Natl. Acad. Sci. 2006, 103:17759-17764.
36. Shu X.Z., Ahmad S., Liu Y., Prestwich G.D. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J. Biomed. Mater. Res. 2006, 79A:902-912.
37. Shear D.A., Tate M.C., Archer D.R., Hoffman S.W., Hulce V.D., LaPlaca M.C., et al. Neural progenitor cell transplants promote long-term functional recovery after traumatic brain injury. Brain Res. 2004, 1026:11-22.
38. Shear D.A., Tate C.C., Tate M.C., Archer D.R., LaPlaca M.C., Stein D.G., et al. Stem cell survival and functional outcome after traumatic brain injury is dependent on transplant timing and location. Restor. Neurol. Neurosci. 2011, 29:215-225.
39. Tate C.C., Shear D.A., Tate M.C., Archer D.R., Stein D.G., LaPlaca M.C. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J. Tissue Eng. Regen. Med. 2009, 3:208-217.
40. Guan J., Zhu Z., Zhao R.C., Xiao Z., Wu C., Han Q., et al. Transplantation of human mesenchymal stem cells loaded on colalgen scaffolds for the treatment of traumatic brain injury in rats. Biomaterials 2013, 34:5937-5946.
41. Wang T.-Y., Forsythe J.S., Nisbet D.R., Parish C.L. Promoting engraftment of transplanted neural stem cells/progenitors using biofunctionalised electrospun scaffolds. Biomaterials 2012, 33:9188-9197.
42. Yu X., Chen D., Zhang Y., Wu X., Huang Z., Zhou H., et al. Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke. J. Neurol. Sci. 2012, 316:141-149.
43. Wang Z., Wang Y., Wang Z., Gutkind S., Wang Z., Wang F., et al. Engineered mesenchymal stem cells with enhanced tropism and paracrine secretion of cytokines and growth factors to treat traumatic brain injury. Stem Cells 2014, 33:456-467.
44. Lu D., Mahmood A., Qu C., Hong X., Kaplan D., Chopp M. Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury. Neurosurgery 2007, 61:596.
45. Qu C., Mahmood A., Liu X.S., Xiong Y., Wang L., Wu H., et al. The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: functional outcome and gene expression profile. Brain Res. 2011, 1371:129-139.
46. Suri S., Schmidt C.E. Cell-laden hydrogel constructs of hyaluronic acid, collagen, and laminin for neural tissue engineering. Tissue Eng. Part A 2010, 16:1703-1716.
47. Tavazoie M., Van der Veken L., Silva-Vargas V., Louissaint M., Colonna L., Zaidi B., et al. A specialized vascular niche for adult neural stem cells. Cell Stem Cell 2008, 3:279-288.
48. Kokovay E., Goderie S., Wang Y., Lotz S., Lin G., Sun Y., et al. Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell 2010, 7:163-173.
49. Preston M., Sherman L.S. Neural stem cell niches: critical roles for the hyaluronan-based extracellular matrix in neural stem cell proliferation and differentiation. Front. Biosci. (Schol. Ed. 2012, 3:1165.
50. Deboux C., Ladraa S., Cazaubon S., Ghribi-Mallah S., Weiss N., Chaverot N., et al. Overexpression of CD44 in neural precursor cells improves trans- endothelial migration and facilitates their invasion of perivascular tissues in vivo. PLoS One 2013, 8:e57430.
51. Tran P.B., Banisadr G., Ren D., Chenn A., Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J. Comput. Neurol. 2006, 500:1007-1034.
52. Cohen M., Kam Z., Addadi L., Geiger B. Dynamic study of the transition from hyaluronan- to integrin-mediated adhesion in chondrocytes. Embo J. 2006, 25:302-311.
53. Lee J.L., Wang M.J., Sudhir P.R., Chen J.Y. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Mol. Cell. Biol. 2008, 28:5710-5723.
54. Martino G., Pluchino S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 2006, 7:395-406.
55. Turley E.A., Noble P.W., Bourguignon L.Y.W. Signaling properties of hyaluronan receptors. J. Biol. Chem. 2002, 277:4589-4592.
56. Wozniak M.A., Modzelewska K., Kwong L., Keely P.J. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta - Mol. Cell Res. 2004, 1692:103-119.
57. Huang Y.-S., Cheng C.-Y., Chueh S.-H., Hueng D.-Y., Huang Y.-F., Chu C.-M., et al. Involvement of SHP2 in focal adhesion, migration and differentiation of neural stem cells. Brain Dev. 2012, 34:674-684.
58. Kim M.-S., Park M.-J., Moon E.-J., Kim S.-J., Lee C.-H., Yoo H., et al. Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells. Cancer Res. 2005, 65:686-691.
59. Rooney P., Wang M., Kumar P., Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J. Cell Sci. 1993, 105:213-218.
60. Price J., Hynes R.O. Astrocytes in culture synthesize and secrete a variant form of fibronectin. J. Neurosci. 1985, 5:2205-2211.
61. Jensen J.B., Parmar M. Strengths and limitations of the neurosphere culture system. Mol. Neurobiol. 2006, 34:153-161.
62. Suslov O.N., Kukekov V.G., Ignatova T.N., Steindler D.A. Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres. Proc. Natl. Acad. Sci. 2002, 99:14506-14511.
63. Wu P.H., Giri A., Sun S.X., Wirtz D. Three-dimensional cell migration does not follow a random walk. Proc. Natl. Acad. Sci. 2014, 111:3949-3954.
64. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 2010, 188:11-19.
65. Fraley S.I., Feng Y., Krishnamurthy R., Kim D.-H., Celedon A., Longmore G.D., et al. A distinctive role for focal adhesion proteins in three- dimensional cell motility. Nat. Publ. Group 2010, 12:598-604.
66. Friedl P., Bröcker E.-B. The biology of cell locomotion within three-dimensional extracellular matrix. Cell. Mol. Life Sci. 2000, 57:41-64.
67. Jacques T.S., Relvas J.B., Nishimura S., Pytela R., Edwards G.M., Streuli C.H. Neural precursor cell chain migration and division are regulated through different beta1 integrins. Development 1998, 125:3167-3177.